BioNTech SE
Statements
Cash Flow
All figures per share in EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.38 | 3.53 | -1.43 | 7.40 | -2.81 | -2.09 | -3.42 | 0.55 | 3.57 | 1.22 | -1.69 | 0.04 | 2.91 | |
| 0.17 | 0.35 | 0.17 | 0.23 | 0.20 | 0.73 | 0.19 | 0.24 | 0.61 | 0.67 | 0.49 | 1.07 | 2.77 | |
| 0.06 | 0.06 | 0.07 | 0.08 | 0.17 | 0.10 | 0.09 | 0.13 | 0.12 | 0.10 | 0.09 | 0.08 | 0.38 | |
| -0.13 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.67 | -7.37 | 1.00 | 10.74 | -2.96 | -3.10 | -1.82 | 2.36 | 3.05 | -0.88 | 0.27 | 2.40 | 4.70 | |
| 0.63 | 1.21 | 0.62 | 0.64 | 0.37 | 0.42 | 2.71 | 2.35 | 0.18 | 0.25 | 0.23 | 0.22 | 0.86 | |
| -5.14 | -11.76 | -10.40 | -1.05 | -0.66 | 2.70 | 5.46 | -0.11 | -4.16 | -10.71 | 10.65 | -0.41 | -4.07 | |
| 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | – | |
| -1.26 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | – | – | – | -0.52 | – | |
| -0.04 | – | – | – | -0.03 | -0.03 | -0.06 | -0.06 | -0.05 | -0.05 | 0.10 | 0.08 | 0.09 | |
| -1.30 | -0.01 | -0.04 | -0.10 | -0.04 | -0.03 | -0.06 | -0.06 | -0.06 | -0.06 | 0.11 | -0.44 | -0.44 | |
| -2.80 | -5.83 | -13.26 | 6.00 | -1.55 | -2.63 | 3.72 | 4.36 | -0.82 | -9.88 | 8.38 | -1.09 | -3.06 | |
| 2.75 | 4.74 | -2.05 | 6.76 | -3.18 | -2.50 | -6.13 | 2.90 | 3.39 | 0.97 | -1.92 | -0.18 | 2.05 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.